{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T19:08:38Z","timestamp":1783796918429,"version":"3.55.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T00:00:00Z","timestamp":1717977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP21010280"],"award-info":[{"award-number":["DP21010280"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["FT230100468"],"award-info":[{"award-number":["FT230100468"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","award":["2021\/AE000311"],"award-info":[{"award-number":["2021\/AE000311"]}],"id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["GNT2012583"],"award-info":[{"award-number":["GNT2012583"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["GNT1162684"],"award-info":[{"award-number":["GNT1162684"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.vaccine.2024.06.027","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T15:50:07Z","timestamp":1718725807000},"page":"126060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Self-assembled monovalent lipidated mannose ligand as a standalone nanoadjuvant"],"prefix":"10.1016","volume":"42","author":[{"given":"Ummey J.","family":"Nahar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed O.","family":"Shalash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7006-4339","authenticated-orcid":false,"given":"Lantian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. T.","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nedaa","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashamsa","family":"Koirala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab G.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Capon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-1880","authenticated-orcid":false,"given":"Waleed M.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7257-807X","authenticated-orcid":false,"given":"Mariusz","family":"Skwarczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.06.027_b0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1089\/vim.2017.0146","article-title":"Opinion: Making Inactivated and Subunit-Based Vaccines Work","volume":"31","author":"Chua","year":"2018","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2024.06.027_b0010","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/21645515.2016.1229719","article-title":"Recent advancements in combination subunit vaccine development","volume":"13","author":"Tan","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.06.027_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1043109","article-title":"New-age vaccine adjuvants, their development, and future perspective","volume":"14","author":"Verma","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.06.027_b0020","first-page":"10","article-title":"An overview of vaccine adjuvants: current evidence and future perspectives","author":"Facciol\u00e0","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.06.027_b0025","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.vaccine.2004.03.032","article-title":"Aluminium adjuvants\u2014in retrospect and prospect","volume":"22","author":"Lindblad","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.06.027_b0030","first-page":"842","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Peptide-based synthetic vaccines Chem Sci"},{"key":"10.1016\/j.vaccine.2024.06.027_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2021.100103","article-title":"Overview of vaccine adjuvants","volume":"11","author":"Wu","year":"2021","journal-title":"Medicine in Drug Discovery"},{"key":"10.1016\/j.vaccine.2024.06.027_b0040","first-page":"13","article-title":"An overview of nanocarrier-based adjuvants for vaccine delivery","author":"Petkar","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2024.06.027_b0045","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/pharmaceutics12100965","article-title":"Carbohydrate immune adjuvants in subunit vaccines","volume":"12","author":"Bashiri","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2024.06.027_b0050","doi-asserted-by":"crossref","unstructured":"Di Pasquale A, Preiss S, Tavares Da Silva F, Garcon N. Vaccine Adjuvants: from 1920 to 2015 and Beyond. Vaccines (Basel). 2015;3:320-43.","DOI":"10.3390\/vaccines3020320"},{"key":"10.1016\/j.vaccine.2024.06.027_b0055","first-page":"145","article-title":"Developments in vaccine adjuvants","volume":"ed2022","author":"Firdaus","year":"2021","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2024.06.027_b0060","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2024.06.027_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.06.027_b0070","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1080\/14760584.2021.1939688","article-title":"Carbohydrate-containing nanoparticles as vaccine adjuvants","volume":"20","author":"Zhang","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.06.027_b0075","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jconrel.2022.09.038","article-title":"Mannose in vaccine delivery","volume":"351","author":"Nahar","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2024.06.027_b0080","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990\u20132015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.06.027_b0085","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41588-019-0417-8","article-title":"Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics","volume":"51","author":"Davies","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2024.06.027_b0090","article-title":"Pathogenesis, epidemiology and control of Group A Streptococcus infection","volume":"1\u201317","author":"Brouwer","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2024.06.027_b0095","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S1473-3099(23)00043-9","article-title":"Surge of invasive group A streptococcus disease","volume":"23","author":"Bagcchi","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.027_b0100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.15585\/mmwr.mm7210a4","article-title":"Notes from the field: increase in pediatric invasive group a streptococcus infections - colorado and minnesota, october-december 2022","volume":"72","author":"Barnes","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.06.027_b0105","doi-asserted-by":"crossref","first-page":"ofad188","DOI":"10.1093\/ofid\/ofad188","article-title":"Unexpected increase in invasive group a streptococcal infections in children after respiratory viruses outbreak in france: a 15-year time-series analysis","volume":"10","author":"Lassoued","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.027_b0110","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41467-023-36717-4","article-title":"Detection of Streptococcus pyogenes M1(UK) in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA","volume":"14","author":"Davies","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.06.027_b0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41541-023-00659-1","article-title":"Global economic burden per episode for multiple diseases caused by group A Streptococcus","volume":"8","author":"Lee","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2024.06.027_b0120","doi-asserted-by":"crossref","DOI":"10.1098\/rsos.201991","article-title":"A brief review on Group A Streptococcus pathogenesis and vaccine development","volume":"8","author":"Castro","year":"2021","journal-title":"R Soc Open Sci"},{"key":"10.1016\/j.vaccine.2024.06.027_b0125","doi-asserted-by":"crossref","unstructured":"Azuar A, Jin W, Mukaida S, Hussein W, Toth I, Skwarczynski M. Recent advances in the development of peptide vaccines and their delivery systems against Group A Streptococcus. Vaccines. 2019;7:10.3390\/vaccines7030058.","DOI":"10.3390\/vaccines7030058"},{"key":"10.1016\/j.vaccine.2024.06.027_b0130","doi-asserted-by":"crossref","first-page":"e0198658","DOI":"10.1371\/journal.pone.0198658","article-title":"Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial","volume":"13","author":"Sekuloski","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.06.027_b0135","first-page":"1038","article-title":"Clinical Evaluation of Safety and Immunogenicity of PADRE-Cytomegalovirus (CMV) and Tetanus-CMV Fusion Peptide Vaccines With or Without PF03512676 Adjuvant (vol 205, pg 1294, 2012)","volume":"208","author":"La Rosa","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.06.027_b0140","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02788751","article-title":"The optimization of helper T lymphocyte (HTL) function in vaccine development","volume":"18","author":"Alexander","year":"1998","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2024.06.027_b0145","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1021\/acs.jmedchem.0c01660","article-title":"Poly(hydrophobic amino acid)-based self-adjuvanting nanoparticles for group a streptococcus vaccine delivery","volume":"64","author":"Azuar","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.vaccine.2024.06.027_b0150","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1021\/acs.bioconjchem.1c00333","article-title":"Poly(hydrophobic amino acid) Conjugates for the Delivery of Multiepitope Vaccine against Group A Streptococcus","volume":"32","author":"Azuar","year":"2021","journal-title":"Bioconjugate Chem"},{"key":"10.1016\/j.vaccine.2024.06.027_b0155","doi-asserted-by":"crossref","first-page":"eaax2285","DOI":"10.1126\/sciadv.aax2285","article-title":"Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines","volume":"6","author":"Skwarczynski","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.vaccine.2024.06.027_b0160","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3390\/vaccines10081212","article-title":"Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus","volume":"10","author":"Azuar","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.06.027_b0165","doi-asserted-by":"crossref","unstructured":"Dai C, Stephenson RJ, Skwarczynski M, Toth I. Application of Fmoc-SPPS, Thiol-Maleimide Conjugation, and Copper(I)-Catalyzed Alkyne-Azide Cycloaddition \u201cClick\u201d Reaction in the Synthesis of a Complex Peptide-Based Vaccine Candidate Against Group A Streptococcus. Methods in molecular biology (Clifton, NJ)2020. p. 13-27.","DOI":"10.1007\/978-1-0716-0227-0_2"},{"key":"10.1016\/j.vaccine.2024.06.027_b0170","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1002\/anie.201002221","article-title":"Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system","volume":"49","author":"Skwarczynski","year":"2010","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.vaccine.2024.06.027_b0175","series-title":"Peptide Conjugation: Methods and Protocols","first-page":"1","article-title":"Peptide-Polymer Conjugation Via Copper-Catalyzed Alkyne-Azide 1,3-Dipolar Cycloaddition","author":"Hussein","year":"2021"},{"key":"10.1016\/j.vaccine.2024.06.027_b0180","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1016\/j.bmc.2016.07.036","article-title":"Multiantigenic peptide-polymer conjugates as therapeutic vaccines against cervical cancer","volume":"24","author":"Hussein","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.vaccine.2024.06.027_b0185","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3390\/pharmaceutics15020602","article-title":"Liposomal Formulations of a Polyleucine-Antigen Conjugate as Therapeutic Vaccines against Cervical Cancer","volume":"15","author":"Firdaus","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.vaccine.2024.06.027_b0190","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.actbio.2016.08.020","article-title":"A semi-synthetic whole parasite vaccine designed to protect against blood stage malaria","volume":"44","author":"Giddam","year":"2016","journal-title":"Acta Biomater"},{"key":"10.1016\/j.vaccine.2024.06.027_b0195","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ab313d","article-title":"Peptide-based targeted polymeric nanoparticles for siRNA delivery","volume":"30","author":"Hussein","year":"2019","journal-title":"Nanotechnology"},{"key":"10.1016\/j.vaccine.2024.06.027_b0200","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10450-016-9767-z","article-title":"Zeta potential and surface charge of DPPC and DOPC liposomes in the presence of PLC enzyme","volume":"22","author":"Chibowski","year":"2016","journal-title":"Adsorption"},{"key":"10.1016\/j.vaccine.2024.06.027_b0205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ddtec.2020.09.005","article-title":"Carbohydrate-based adjuvants","volume":"35\u201336","author":"Garcia-Vello","year":"2020","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.vaccine.2024.06.027_b0210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41570-020-00244-3","article-title":"Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action","volume":"5","author":"Pifferi","year":"2021","journal-title":"Nat Rev Chem"},{"key":"10.1016\/j.vaccine.2024.06.027_b0215","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.06.027_b0220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biomaterials.2019.03.012","article-title":"Co-delivery of antigen and dual agonists by programmed mannose-targeted cationic lipid-hybrid polymersomes for enhanced vaccination","volume":"206","author":"Zhu","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2024.06.027_b0225","doi-asserted-by":"crossref","first-page":"9571","DOI":"10.2147\/IJN.S275670","article-title":"Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice","volume":"15","author":"Zhao","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.vaccine.2024.06.027_b0230","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/17425247.5.6.703","article-title":"Mannose-targeted systems for the delivery of therapeutics","volume":"5","author":"Irache","year":"2008","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.vaccine.2024.06.027_b0235","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1021\/acs.molpharmaceut.1c00447","article-title":"Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines","volume":"18","author":"Chatzikleanthous","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2024.06.027_b0240","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3390\/nano10050823","article-title":"Development of polyelectrolyte complexes for the delivery of peptide-based subunit vaccines against group A streptococcus","volume":"10","author":"Zhao","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.vaccine.2024.06.027_b0245","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1573406412666160720093138","article-title":"The Role of Size in Development of Mucosal Liposome-Lipopeptide Vaccine Candidates against Group A Streptococcus","volume":"13","author":"Ghaffar","year":"2017","journal-title":"Med Chem"},{"key":"10.1016\/j.vaccine.2024.06.027_b0250","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.actbio.2016.04.012","article-title":"Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus","volume":"41","author":"Ghaffar","year":"2016","journal-title":"Acta Biomater"},{"key":"10.1016\/j.vaccine.2024.06.027_b0255","doi-asserted-by":"crossref","first-page":"e0265721","DOI":"10.1128\/mBio.02657-21","article-title":"Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria","volume":"12","author":"Stanisic","year":"2021","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2024.06.027_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00135","article-title":"Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines","volume":"10","author":"Ssemaganda","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.06.027_b0265","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.chom.2021.04.008","article-title":"Pre-clinical evaluation of a whole-parasite vaccine to control human babesiosis","volume":"29","author":"Al-Nazal","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2024.06.027_b0270","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2217\/nnm.12.157","article-title":"Liposome-based delivery system for vaccine candidates: constructing an effective formulation","volume":"7","author":"Giddam","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.vaccine.2024.06.027_b0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2018.08.020","article-title":"Cationic lipids as one-component vaccine adjuvants: A promising alternative to alum","volume":"287","author":"Pizzuto","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2024.06.027_b0280","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2174\/1568026614666140329232757","article-title":"Liposomes as nanovaccine delivery systems","volume":"14","author":"Ghaffar","year":"2014","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.vaccine.2024.06.027_b0285","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00980","article-title":"Optimization of the Linker Length of Mannose-Cholesterol Conjugates for Enhanced mRNA Delivery to Dendritic Cells by Liposomes","volume":"9","author":"Wang","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.vaccine.2024.06.027_b0290","first-page":"4545","article-title":"Effect of space length of mannose ligand on uptake of mannosylated liposome in RAW 264.7 cells: In vitro and in vivo studies","volume":"102","author":"Jeong","year":"2014","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.vaccine.2024.06.027_b0295","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2006.04.010","article-title":"Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated O\/W emulsions by macrophages","volume":"114","author":"Yeeprae","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2024.06.027_b0300","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1021\/mp400216r","article-title":"Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles","volume":"10","author":"Zhu","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2024.06.027_b0305","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1016\/j.biomaterials.2010.12.054","article-title":"The impact of nanoparticle ligand density on dendritic-cell targeted vaccines","volume":"32","author":"Bandyopadhyay","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2024.06.027_b0310","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1021\/bc8002524","article-title":"Influence of Ligand Valency on the Targeting of Immature Human Dendritic Cells by Mannosylated Liposomes","volume":"19","author":"Espuelas","year":"2008","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.vaccine.2024.06.027_b0315","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1039\/D1BM01333E","article-title":"Physical mixture of a cyclic lipopeptide vaccine induced high titres of opsonic IgG antibodies against group A streptococcus","volume":"10","author":"Madge","year":"2021","journal-title":"Biomater Sci"},{"key":"10.1016\/j.vaccine.2024.06.027_b0320","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/bmj.321.7258.424","article-title":"Th1 and Th2 responses: what are they?","volume":"321","author":"Berger","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2024.06.027_b0325","doi-asserted-by":"crossref","first-page":"e1002003","DOI":"10.1371\/journal.ppat.1002003","article-title":"Evolution of Th2 Immunity: A Rapid Repair Response to Tissue Destructive Pathogens","volume":"7","author":"Allen","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2024.06.027_b0330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.gene.6363645","article-title":"Cytokine gene polymorphism in human disease: on-line databases","volume":"1","author":"Bidwell","year":"1999","journal-title":"Genes Immun"},{"key":"10.1016\/j.vaccine.2024.06.027_b0335","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.4049\/jimmunol.161.8.4000","article-title":"Lipid vesicle size determines the Th1 or Th2 response to entrapped antigen","volume":"161","author":"Brewer","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.06.027_b0340","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-1759(98)00015-5","article-title":"The need for IgG2c specific antiserum when isotyping antibodies from C57BL\/6 and NOD mice","volume":"212","author":"Martin","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2024.06.027_b0345","doi-asserted-by":"crossref","first-page":"e1719","DOI":"10.1371\/journal.pntd.0001719","article-title":"Kinetics of Antibody Response in BALB\/c and C57BL\/6 Mice Bitten by Phlebotomus papatasi","volume":"6","author":"Vlkova","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.06.027_b0350","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.06.027_b0355","doi-asserted-by":"crossref","first-page":"e00122","DOI":"10.1128\/mBio.00122-20","article-title":"Vaccine-induced Th1-type response protects against invasive Group A Streptococcus infection in the absence of opsonizing antibodies","volume":"11","author":"Rivera-Hernandez","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2024.06.027_b0360","article-title":"Key Considerations for the Development of Safe and Effective SARS-CoV-2 Subunit Vaccine: A Peptide-Based Vaccine Alternative","volume":"2100985","author":"Shalash","year":"2021","journal-title":"Adv Sci"},{"key":"10.1016\/j.vaccine.2024.06.027_b0365","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.4049\/jimmunol.1202246","article-title":"IL-4 in the brain: a cytokine to remember","volume":"189","author":"Gadani","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.06.027_b0370","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1073\/pnas.86.10.3803","article-title":"Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2","volume":"86","author":"Hart","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2024.06.027_b0375","series-title":"The Cytokines of the Immune System","first-page":"143","article-title":"Chapter 6 - Cytokines of the Immune System: Interleukins","author":"Dembic","year":"2015"},{"key":"10.1016\/j.vaccine.2024.06.027_b0380","doi-asserted-by":"crossref","first-page":"2001264","DOI":"10.1002\/advs.202001264","article-title":"Self-Assembling Glycopeptide Conjugate as a Versatile Platform for Mimicking Complex Polysaccharides","volume":"7","author":"Wang","year":"2020","journal-title":"Adv Sci"},{"key":"10.1016\/j.vaccine.2024.06.027_b0385","series-title":"Lipid-core-peptide system for self-adjuvanting synthetic vaccine delivery","first-page":"297","author":"Skwarczynski","year":"2011"},{"key":"10.1016\/j.vaccine.2024.06.027_b0390","series-title":"Vaccine Design: Methods and Protocols, Volume 3 Resources for Vaccine Development","first-page":"295","article-title":"Liposomes for the Delivery of Lipopeptide Vaccines","author":"Yang","year":"2022"},{"key":"10.1016\/j.vaccine.2024.06.027_b0395","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.slast.2021.10.002","article-title":"Enabling high throughput drug discovery in 3D cell cultures through a novel bioprinting workflow","volume":"27","author":"Engel","year":"2022","journal-title":"SLAS Technology"},{"key":"10.1016\/j.vaccine.2024.06.027_b0400","article-title":"Utilizing murine dendritic cell line DC2.4 to evaluate the immunogenicity of subunit vaccines in vitro","volume":"15","author":"Lu","year":"2024","journal-title":"Front Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24007011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:44:05Z","timestamp":1773182645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24007011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":80,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0264410X24007011"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-assembled monovalent lipidated mannose ligand as a standalone nanoadjuvant","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126060"}}